EMA warns of increased risk for pulmonary embolism and death with higher dose of tofacitinib - medwireNews

EMA warns of increased risk for pulmonary embolism and death with higher dose of tofacitinib  medwireNews

medwireNews: The EMA has issued a safety alert warning that the recommended 5 mg twice daily dose of the Janus kinase inhibitor tofacitinib should not be ...



Comments

Post a Comment

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma    Global Banking And Finance Review Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Read more